Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis - Comparison with stable and unstable angina

Inflammation Research

Volumn 54, Issue 5, 2005, Pages 187-193

  Kozinski, M ^a   Krzewina Kowalska, A ^a   Kubica, J ^a   Zbikowska Gotz, M ^a   Dymek, G ^a   Piasecki, R ^a   Sukiennik, A ^a   Grzesk, G ^a   Bogdan, M ^a   Chojnicki, M ^a   Dziedziczko, A ^a   Sypniewska, G ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

C reactive protein; Inflammation; Percutaneous coronary intervention; Serum amyloid A; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ANGINA PECTORIS; ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; MALE; SERUM AMYLOID A PROTEIN; STENTS; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21144441360     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-005-1342-0     Document Type: Article

References (40)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Moreno PR, Bernardi VH, Lopez-Cuellar J, Newell JB, McMellon C, Gold HK et al. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996; 94: 3098-102.
3. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002; 105: 2974-80.
4. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-97.
6. van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A, Witteman JC. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med 2003; 163: 1323-8.
7. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-3.
8. Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Ramazzotti V, Rebuzzi AG et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34: 1512-21.
9. Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schachinger V, Zeiher AM. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001; 37: 839-46.
10. Grander W, Dichtl W, Prokop W, Roithinger FX, Moes N, Friedrich G et al. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention. Clin Cardiol 2004; 27: 211-6.
11. Segev A, Kassam S, Buller CE, Lau HK, Sparkes JD, Connelly PW et al. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Eur Heart J 2004; 25: 1029-35.
12. Gomma AH, Hirschfield GM, Gallimore JR Jr, Lowe GD, Pepys MB, Fox KM. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am Heart J 2004; 147: 1071-7.
13. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98: 2370-6.
14. Sanchez-Margalet V, Cubero JM, Martin-Romero C, Cubero J, Cruz-Fernandez JM, Goberna R. Inflammatory response to coronary stent implantation in patients with unstable angina. Clin Chem Lab Med 2002; 40: 769-74.
15. Almagor M, Keren A, Banai S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am Heart J 2003; 145: 248-53.
16. Erdogan O, Altun A, Gul C, Ozbay G. C-reactive protein and immunoglobulin-E response to coronary artery stenting in patients with stable angina. Jpn Heart J 2003; 44: 593-600.
17. Bhatt DL. Inflammation and restenosis: is there a link? Am Heart J 2004; 147: 945-7.
18. Schillinger M, Exner M, Mlekusch W, Rumpold H, Ahmadi R, Sabeti S et al. Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis. Radiology 2003; 227: 516-21.
19. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, Wexberg P et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21: 1152-8.
20. Krzewina-Kowalska A, Kubica J, Koziński M, Piasecki R, Berent B, Bogdan M et al. [Selected acute phase proteins in patients undergoing coronary angioplasty]. Folia Cardiologica 2003; 10: 733-42.
21. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 327-34.
22. Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I et al. Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol 2002; 40: 1935-42.
23. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763-71.
24. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
25. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992; 4: 361-8.
26. Tipping PG, Hancock WW. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol 1993; 142: 1721-8.
27. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-53.
28. Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004; 43: 18-23.
29. Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C et al. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 2004; 92: 419-24.
30. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002; 39: 1917-23.
31. Benamer H, Steg PG, Benessiano J, Vicaut E, Gaultier CJ, Boccara A et al. Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris. Am J Cardiol 1998; 82: 845-50.
32. Saadeddin SM, Habbab MA. Percutaneous coronary intervention in the context of systemic inflammation: more injury and worse outcome. Med Sci Monit 2003; 9: RA193-7.
33. Goldberg A, Zinder O, Zdorovyak A, Diamond E, Lischinsky S, Gruberg L et al. Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina. Am Heart J 2003; 146: 819-23.
34. Laskey WK, Gellman J. Inflammatory markers increase following exposure to radiographic contrast media. Acta Radiol 2003; 44: 498-503.
35. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002; 22: 1769-76.
36. Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol 2000; 86: 1057-62.
37. Rogers C, Welt FG, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996; 16: 1312-8.
38. Welt FG, Edelman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000; 20: 2553-8.
39. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-6.
40. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 77: 723-7.